Michael Heltzen
Directeur Général chez Invizyne Technologies, Inc.
Profil
Michael Heltzen is the founder of Nanosens Innovations, Inc. He is currently the Chief Executive Officer at Invizyne Technologies, Inc. since 2024.
He is also currently serving as the Chairman at Exo Incubator, Inc. since 2015 and at BlueSEQ Innovations, Inc. since 2010.
Previously, he was the Chief Executive Officer at Cardea Bio, Inc. from 2019 to 2023.
He also held a position as Director at CRISPRQC, Inc. and as Vice President-Strategy at Paragraf Ltd.
in 2023.
Postes actifs de Michael Heltzen
| Sociétés | Poste | Début |
|---|---|---|
Invizyne Technologies, Inc.
 Invizyne Technologies, Inc. Chemicals: SpecialtyProcess Industries Invizyne Technologies, Inc. is a development stage synthetic biochemical company. Its synthetic biology platform would enable the scalable exploration of many molecules and properties found in nature. The company was founded by Tyler Korman and Paul Opgenorth in April 2019 and is headquartered in Monrovia, NV. | Directeur Général | 01/02/2024 |
EXO INCUBATOR, INC.
 EXO INCUBATOR, INC. BiotechnologyHealth Technology Exo Incubator, Inc. operates as a biotechnology firm that focuses on biomedical technology incubation and research. The private company is based in San Diego. | Président | 01/01/2015 |
Anciens postes connus de Michael Heltzen
| Sociétés | Poste | Fin |
|---|---|---|
Paragraf Ltd.
 Paragraf Ltd. Electrical ProductsProducer Manufacturing Paragraf Ltd. operates as a graphene technology development firm. Its products include graphene layers, heterostructures, thin film material heterostructures, and graphene devices as well as novel 2D materials. The company was founded on November 25, 2015 and is headquartered in , the Cambridgeshire,United Kingdom. | Corporate Officer/Principal | 01/10/2023 |
Cardea Bio, Inc.
 Cardea Bio, Inc. BiotechnologyHealth Technology Cardea Bio, Inc. develops bioelectronics for use in research and diagnostics. Its products include AGILE 100 and pipeline. The company was founded by Ross Bundy, Kiana Aran, and Brett Goldsmith in 2013 and is headquartered in San Diego, CA. | Directeur Général | 01/05/2023 |
CRISPRQC, Inc.
 CRISPRQC, Inc. BiotechnologyHealth Technology CRISPRQC, Inc. provides a comprehensive crispr analytics platform that enables scientists and researchers to optimize gene editing outcomes and ensure the highest levels of quality control. The company is based in San Diego, CA. The platform is built on the company's proprietary crispr-chip technology, which allows for direct, real-time measurement of crispr activity. The company strives to empower its customers with the insights needed to push forward the life-saving cures and sustainable agricultural advances fueled by crispr editing. CRISPRQC was founded by Ross Bundy and Kiana Aran, with Ross Bundy serving as the CEO since incorporation. | Directeur/Membre du Conseil | - |
Nanosens Innovations, Inc.
 Nanosens Innovations, Inc. BiotechnologyHealth Technology Nanosens Innovations, Inc. develops bioelectronics for use in research and diagnostics. It sells CRISPR-Chip technology based products under the Nanosens brand. The company was founded by Kiana Aran and Michael Heltzen and is headquartered in San Diego, CA. | Directeur Général | 01/09/2019 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Cardea Bio, Inc.
Cardea Bio, Inc. BiotechnologyHealth Technology Cardea Bio, Inc. develops bioelectronics for use in research and diagnostics. Its products include AGILE 100 and pipeline. The company was founded by Ross Bundy, Kiana Aran, and Brett Goldsmith in 2013 and is headquartered in San Diego, CA. | Health Technology |
Paragraf Ltd.
Paragraf Ltd. Electrical ProductsProducer Manufacturing Paragraf Ltd. operates as a graphene technology development firm. Its products include graphene layers, heterostructures, thin film material heterostructures, and graphene devices as well as novel 2D materials. The company was founded on November 25, 2015 and is headquartered in , the Cambridgeshire,United Kingdom. | Producer Manufacturing |
Nanosens Innovations, Inc.
Nanosens Innovations, Inc. BiotechnologyHealth Technology Nanosens Innovations, Inc. develops bioelectronics for use in research and diagnostics. It sells CRISPR-Chip technology based products under the Nanosens brand. The company was founded by Kiana Aran and Michael Heltzen and is headquartered in San Diego, CA. | Health Technology |
Invizyne Technologies, Inc.
Invizyne Technologies, Inc. Chemicals: SpecialtyProcess Industries Invizyne Technologies, Inc. is a development stage synthetic biochemical company. Its synthetic biology platform would enable the scalable exploration of many molecules and properties found in nature. The company was founded by Tyler Korman and Paul Opgenorth in April 2019 and is headquartered in Monrovia, NV. | Process Industries |
CRISPRQC, Inc.
CRISPRQC, Inc. BiotechnologyHealth Technology CRISPRQC, Inc. provides a comprehensive crispr analytics platform that enables scientists and researchers to optimize gene editing outcomes and ensure the highest levels of quality control. The company is based in San Diego, CA. The platform is built on the company's proprietary crispr-chip technology, which allows for direct, real-time measurement of crispr activity. The company strives to empower its customers with the insights needed to push forward the life-saving cures and sustainable agricultural advances fueled by crispr editing. CRISPRQC was founded by Ross Bundy and Kiana Aran, with Ross Bundy serving as the CEO since incorporation. | Health Technology |
EXO INCUBATOR, INC.
EXO INCUBATOR, INC. BiotechnologyHealth Technology Exo Incubator, Inc. operates as a biotechnology firm that focuses on biomedical technology incubation and research. The private company is based in San Diego. | Health Technology |